|
Originally published In Press as doi:10.1074/jbc.M208296200 on September 12, 2002
J. Biol. Chem., Vol. 277, Issue 46, 43873-43880, November 15, 2002
The Human Reduced Folate Carrier Gene Is Regulated by the AP2 and
Sp1 Transcription Factor Families and a Functional 61-Base Pair
Polymorphism*
Johnathan R.
Whetstine ,
Teah L.
Witt§, and
Larry H.
Matherly §¶
From the Department of Pharmacology, and the
§ Experimental and Clinical Therapeutics Program,
Barbara Ann Karmanos Cancer Institute, Wayne State University School of
Medicine, Detroit, Michigan 48201
Recently, our laboratory reported an intricate
regulation of the human reduced folate carrier (hRFC) gene,
involving multiple promoters and noncoding exons. We localized promoter
activity to a 452-bp GC-rich region upstream of noncoding exon A,
including a 47-bp basal promoter with a CRE/AP-1-like consensus element that bound the bZip family of DNA-binding proteins (e.g.
CREB-1 and c-Jun). We now report that three nearly identical
tandem repeats (49-61 bp) in the hRFC-A upstream region are involved
in regulating promoter activity. By in vitro binding
assays, multiple transcription factors (e.g. AP2 and
Sp1/Sp3) bound this region. When AP2 was cotransfected with the hRFC-A
reporter construct into HT1080 cells, promoter activity increased
3-fold. In Drosophila SL2 cells, Sp1 transactivated
promoter A and showed synergism with CREB-1. However, c-Jun was
antagonistic to the effects of Sp1. A sequence variant in the hRFC-A
repeated region was identified, involving an exact duplication of a
61-bp sequence. This variant had an allelic frequency of 78% in 72 genomic DNAs and resulted in a 63% increase in promoter activity.
These results identify important regions in the hRFC-A promoter and
critical roles for AP2 and Sp1, in combination with the bZip
transcription factors. Moreover, they document a functionally novel
polymorphism that increases promoter activity and may contribute to
interpatient variations in hRFC expression and effects on tissue folate
homeostasis and antitumor response to antifolates.
*
This work was supported by NCI, National Institutes of
Health, Grant CA53535.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Experimental and
Clinical Therapeutics Program, Karmanos Cancer Institute, 110 E. Warren
Ave., Detroit, MI 48201. Tel.: 313-833-0715 (ext. 2407); Fax:
313-832-7294; E-mail: matherly@karmanos.org.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. J. McGuire, W. H. Haile, and C.-C. Yeh
5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
Cancer Res.,
April 1, 2006;
66(7):
3836 - 3844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Liu, Y. Ge, S. G. Payton, A. Aboukameel, S. Buck, R. M. Flatley, C. Haska, R. Mohammad, J. W. Taub, and L. H. Matherly
Transcriptional Regulation of the Human Reduced Folate Carrier in Childhood Acute Lymphoblastic Leukemia Cells
Clin. Cancer Res.,
January 15, 2006;
12(2):
608 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Liu, Y. Ge, D. C. Cabelof, A. Aboukameel, A. R. Heydari, R. Mohammad, and L. H. Matherly
Structure and Regulation of the Murine Reduced Folate Carrier Gene: IDENTIFICATION OF FOUR NONCODING EXONS AND PROMOTERS AND REGULATION BY DIETARY FOLATES
J. Biol. Chem.,
February 18, 2005;
280(7):
5588 - 5597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Flatley, S. G. Payton, J. W. Taub, and L. H. Matherly
Primary Acute Lymphoblastic Leukemia Cells Use a Novel Promoter and 5'Noncoding Exon for the Human Reduced Folate Carrier That Encodes a Modified Carrier Translated from an Upstream Translational Start
Clin. Cancer Res.,
August 1, 2004;
10(15):
5111 - 5122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rothem, M. Stark, Y. Kaufman, L. Mayo, and Y. G. Assaraf
Reduced Folate Carrier Gene Silencing in Multiple Antifolate-resistant Tumor Cell Lines Is Due to a Simultaneous Loss of Function of Multiple Transcription Factors but Not Promoter Methylation
J. Biol. Chem.,
January 2, 2004;
279(1):
374 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Li, J. R. Dedman, and M. A. Kaetzel
Intron Disruption of the Annexin IV Gene Reveals Novel Transcripts
J. Biol. Chem.,
October 31, 2003;
278(44):
43276 - 43283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gay, D. Calvo, M.-C. Lo, J. Ceron, M. Maduro, R. Lin, and Y. Shi
Acetylation regulates subcellular localization of the Wnt signaling nuclear effector POP-1
Genes & Dev.,
March 15, 2003;
17(6):
717 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|